Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Depression and Cocaine Dependence
NCT00249444Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- May 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in cocaine dependence, major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started May 2006; status: completed.
02
Drugs
mirtazapine
03
Conditions
cocaine dependencemajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00249444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249444.